GlucoMe, a comprehensive, digital diabetes care platform that intends to streamlines the disease management process for patients, medical teams and healthcare providers, announced yesterday that it has collaborated with Switzerland-based Roche as a new partner due to its involvement in the current Startup Creasphere Batch 2 Program.
Set-up by Roche and Plug and Play to accelerate digital healthcare Startup Creasphere is the first digital health innovation hub in Europe. GlucoMe was chosen to collaborate with Roche from one of 11 companies that are participating in the global initiative, following a screening process of more than 200 health-focused start-up companies.
GlucoMe's CEO, Yiftah Ben-Aharon, said, 'We are excited to partner with Roche and Plug & Play. From some very tough competition involving world-class promising digital health start-ups, the new Roche partnership will help GlucoMe rapidly advance our digital diabetes platform to set a new standard in diabetes care delivery.'
Ocular Therapeutix prices USD475m common stock offering
Early, Evidence-Led Cardiovascular Care Strengthened in High-Risk MENA Regions
Nanomi BV to acquire ophthalmology specialist VISUfarma BV
AstraZeneca launches online platform to expand patient access to medications
Avant Technologies enters joint venture to advance stem cell-based diabetes treatments
Innovent and Ollin report progress in development of OLN324 (IBI324)
Alteogen secures European Commission approval for aflibercept biosimilar EYLUXVI
Eli Lilly and Company's orforglipron outperforms oral semaglutide in Phase 3 ACHIEVE-3 trial
Ascletis presents ASC30 study results at EASD Annual Meeting
Kodiak reports positive APEX data for KSI-101 in macular edema secondary to inflammation
Renalytix signs collaboration agreement with Tempus AI to expand KidneyIntelX.dkd access
Diamyd Medical secures Eurasian patent for insulin-based antigen therapy in type 1 diabetes
Novo Nordisk to streamline operations and reinvest in diabetes and obesity growth